The calcium channel blocker Cav2.1 combined with amyloid beta monoclonal antibodies may reduce the occurrence of ARIA‐E
The use of calcium channel blockers Cav2.1, in combination with monoclonal antibodies may provide a new intervention strategy to reduce the occurrence and alleviate the symptoms of ARIA-E.
Authors
- Xiaotong Li (ORCID: https://orcid.org/0000-0002-7279-532X)
- Dinghao An (ORCID: https://orcid.org/0009-0009-0688-9174)
- Yun Xu
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_096419
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00